|1.||Alhonen, Leena: 4 articles (01/2011 - 01/2008)|
|2.||Jin, Hai-Tao: 4 articles (01/2011 - 01/2008)|
|3.||Sand, Juhani: 4 articles (01/2011 - 01/2008)|
|4.||Nordback, Isto: 4 articles (01/2011 - 01/2008)|
|5.||Andersson, Roland: 4 articles (06/2007 - 10/2002)|
|6.||Lämsä, Teemu: 3 articles (01/2011 - 07/2008)|
|7.||Räty, Sari: 3 articles (01/2011 - 07/2008)|
|8.||Herzig, Karl-Heinz: 3 articles (01/2011 - 01/2008)|
|9.||Hyvönen, Mervi T: 3 articles (01/2011 - 07/2008)|
|10.||Cheng, Kunrong: 3 articles (02/2009 - 04/2007)|
07/01/2008 - "A polyamine analog bismethylspermine ameliorates severe pancreatitis induced by intraductal infusion of taurodeoxycholate."
07/01/2005 - "In the present study, acute pancreatitis (AP) was induced by the intraductal infusion of 5% sodium taurodeoxycholate in the rat. "
03/01/1996 - "The present study evaluated the enteric bacterial translocation, bacterial homeostasis, and reticuloendothelial system function in experimental acute pancreatitis induced by intraductal injection of 5% sodium taurodeoxycholate in the rat. "
01/01/2011 - "Acute pancreatitis was induced by an infusion of 2 or 6% taurodeoxycholate before Me(2)Spm administration. "
01/01/2011 - "Compared with the transgenic model, no extensive apoptosis was found in taurodeoxycholate pancreatitis. "
|2.||Acute Necrotizing Pancreatitis
01/21/2006 - "Acute necrotizing pancreatitis was induced by retrograde infusion of sodium taurodeoxycholate into the pancreatobiliary duct in rats. "
01/01/1998 - "This study examined the prophylactic and therapeutic effects of different doses of octreotide on retrograde sodium taurodeoxycholate-induced acute necrotizing pancreatitis in rats. "
12/14/2007 - "To investigate the effect of exogenous erythro-poietin (EPO) administration on acute lung injury (ALI) in an experimental model of sodium taurodeoxycholate- induced acute necrotizing pancreatitis (ANP). "
01/01/2004 - "The aim of the study was to evaluate the effects of a non-selective NO synthase inhibitor, nitro-L-arginine methyl ester (L-NAME), and an inducible NO synthase inhibitor, L-canavanine, on sodium taurodeoxycholate-induced acute necrotizing pancreatitis in rats. "
01/01/2012 - "This was partially confirmed by an increase in plasma bile acids (e.g., chenodeoxycholic acid [CDCA] and taurodeoxycholic acid [TDCA]) observed in 48 patients on the day severe sepsis was diagnosed; unlike bilirubin (area under the receiver-operating curve: 0.59), these bile acids predicted 28-d mortality with high sensitivity and specificity (area under the receiver-operating curve: CDCA: 0.77; TDCA: 0.72; CDCA+TDCA: 0.87). "
08/01/1998 - "The present study evaluated the effect of a PAF antagonist, lexipafant (an (S)-4-methyl-2[methyl-imidazo[4,5-c]pyridin-1-ylmethyl)-benzene sulphonyl]-amino]pentanoic acid ethyl ester, BB-882; British Biotech Ltd.), on the potential prevention of gut barrier dysfunction, by measuring gut origin sepsis, bidirectional permeability of the intestinal barrier, and pancreatic capillary endothelial barrier integrity, in acute pancreatitis induced by intraductal infusion of 5% sodium taurodeoxycholate. "
08/01/1980 - "A previously validated in vitro technique was used to study the unidirectional flux rate (Jd) of cholesterol and a homologous series of saturated fatty acids (FA) into the jejunum and ileum of rats and alloxan or streptozotocin-induced diabetes mellitus (DM), under conditions of variable resistance of the intestinal unstirred water layer (UWL), and under conditions of varying concentrations of taurodeoxycholic acid (TDC). "
|2.||NG-Nitroarginine Methyl Ester (L-NAME)
|3.||Nitric Oxide Synthase (NO Synthase)
|6.||Fatty Acids (Saturated Fatty Acids)